UCL CENTRE FOR INTERNATIONAL HEALTH AND DEVELOPMENT (CIHD)

Research carried out at the UCL Institute of Child Health and Great Ormond Street Hospital has identified that the gene causing red hair - melanocortin-1-receptor (MC1R) - is more common in children with Congenital Melanocytic Naevi (CMN), a rare form of birthmark.

Five medical researchers from UCL have been recognised for excellence in medical science by election to the Fellowship of the Academy of Medical Sciences.

An evaluation of the national cleanyourhands campaign shows for the first time that an effective hand-hygiene campaign, undertaken in the context of a high profile political drive, can successfully reduce some healthcare associated infections, according to a new study published in the BMJ.

A genetic finding could help to explain why influenza becomes a life-threatening disease for some people, and yet has only a mild effect on others. Collaborative research led by scientists at UCL and the Wellcome Trust Sanger Institute found that people who carry a particular variant of the IFITM3 gene are significantly more likely to be hospitalised when they fall ill with influenza than those who carry other variants.

A conference titled ‘Tuberculosis: Local and Global’ is being held today (24 March) at UCL to mark World TB Day.

The UK's first robotic surgery training centre has opened at the University College Hospital (UCH) with plans to offer pioneering specialist training to healthcare professionals from all around the world.

The 2011 UCL Research Strategy calls for a transformation of the understanding of the role of our comprehensive research-intensive university in the 21st century.

UCL has moved closer to reducing health inequality present in the UK after the launch of the new UCL Institute of Health Equity by Professor Sir Michael Marmot (UCL Epidemiology & Public Health) and Health Secretary Andrew Lansley.

UCL has announced details of a new EPSRC Centre which will boost innovation in the manufacture of new medicines, improving cost-effectiveness and making the drugs more widely available. The EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies is being funded by a £4.9m grant from the Engineering and Physical Sciences Research Council (EPSRC), with a further £3.9m investment (cash & in-kind) provided by over 25 founding industry partners.

The Bloomsbury Institute for Pathogen Research (BiPR), a joint venture between UCL and the London School of Hygiene & Tropical Medicine (LSHTM), was launched this week.